Abstract
The most effective treatment for advanced head and neck cancer is cisplatin concomitant radiotherapy. However, its use is limited due to its toxicities, especially the nephrotoxicity, which is mainly caused by oxidative stress. There is a necessity to identify new biomarkers of nephrotoxicity, since traditional markers are poorly sensitive and non-specific. Among the biomarkers studied, w…